Table of Contents

1 Study Coverage

• 1.1 Activin A Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Activin A Market Size Growth Rate by Product
  • 1.4.2 IL-4
  • 1.4.3 GM-CSF
  • 1.4.4 Others
• 1.5 Market by End User
  • 1.5.1 Global Activin A Market Size Growth Rate by End User
  • 1.5.2 Human
  • 1.5.3 Animal
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Activin A Market Size
  • 2.1.1 Global Activin A Revenue 2014-2025
  • 2.1.2 Global Activin A Sales 2014-2025
• 2.2 Activin A Growth Rate by Regions
  • 2.2.1 Global Activin A Sales by Regions
  • 2.2.2 Global Activin A Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Activin A Sales by Manufacturers
  • 3.1.1 Activin A Sales by Manufacturers
  • 3.1.2 Activin A Sales Market Share by Manufacturers
  • 3.1.3 Global Activin A Market Concentration Ratio (CR5 and HHI)
• 3.2 Activin A Revenue by Manufacturers
  • 3.2.1 Activin A Revenue by Manufacturers (2014-2019)
  • 3.2.2 Activin A Revenue Share by Manufacturers (2014-2019)
• 3.3 Activin A Price by Manufacturers
• 3.4 Activin A Manufacturing Base Distribution, Product Types
  • 3.4.1 Activin A Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Activin A Product Type
  • 3.4.3 Date of International Manufacturers Enter into Activin A Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Activin A Sales by Product
• 4.2 Global Activin A Revenue by Product
• 4.3 Activin A Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Activin A Breakdown Data by End User

6 North America

• 6.1 North America Activin A by Countries
  • 6.1.1 North America Activin A Sales by Countries
  • 6.1.2 North America Activin A Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Activin A by Product
• 6.3 North America Activin A by End User

7 Europe

• 7.1 Europe Activin A by Countries
  • 7.1.1 Europe Activin A Sales by Countries
  • 7.1.2 Europe Activin A Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Activin A by Product
• 7.3 Europe Activin A by End User

8 Asia Pacific

• 8.1 Asia Pacific Activin A by Countries
  • 8.1.1 Asia Pacific Activin A Sales by Countries
  • 8.1.2 Asia Pacific Activin A Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Activin A by Product
• 8.3 Asia Pacific Activin A by End User

9 Central & South America

• 9.1 Central & South America Activin A by Countries
  • 9.1.1 Central & South America Activin A Sales by Countries
  • 9.1.2 Central & South America Activin A Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Activin A by Product
• 9.3 Central & South America Activin A by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Activin A by Countries
  • 10.1.1 Middle East and Africa Activin A Sales by Countries
  • 10.1.2 Middle East and Africa Activin A Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Activin A by Product
• 10.3 Middle East and Africa Activin A by End User

11 Company Profiles

• 11.1 Ajinomoto
  • 11.1.1 Ajinomoto Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Ajinomoto Activin A Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Ajinomoto Activin A Products Offered
  • 11.1.5 Ajinomoto Recent Development
• 11.2 IBL
  • 11.2.1 IBL Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 IBL Activin A Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 IBL Activin A Products Offered
  • 11.2.5 IBL Recent Development
• 11.3 Japan SLC
  • 11.3.1 Japan SLC Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Japan SLC Activin A Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Japan SLC Activin A Products Offered
  • 11.3.5 Japan SLC Recent Development
• 11.4 Thermo Fisher Scientific
  • 11.4.1 Thermo Fisher Scientific Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Thermo Fisher Scientific Activin A Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Thermo Fisher Scientific Activin A Products Offered
  • 11.4.5 Thermo Fisher Scientific Recent Development
• 11.5 Sigma-Aldrich
  • 11.5.1 Sigma-Aldrich Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Sigma-Aldrich Activin A Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Sigma-Aldrich Activin A Products Offered
  • 11.5.5 Sigma-Aldrich Recent Development
• 11.6 STEMCELL
  • 11.6.1 STEMCELL Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 STEMCELL Activin A Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 STEMCELL Activin A Products Offered
  • 11.6.5 STEMCELL Recent Development
• 11.7 PeproTech
  • 11.7.1 PeproTech Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 PeproTech Activin A Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 PeproTech Activin A Products Offered
  • 11.7.5 PeproTech Recent Development

12 Future Forecast

• 12.1 Activin A Market Forecast by Regions
  • 12.1.1 Global Activin A Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Activin A Revenue Forecast by Regions 2019-2025
• 12.2 Activin A Market Forecast by Product
  • 12.2.1 Global Activin A Sales Forecast by Product 2019-2025
  • 12.2.2 Global Activin A Revenue Forecast by Product 2019-2025
• 12.3 Activin A Market Forecast by End User
• 12.4 North America Activin A Forecast
• 12.5 Europe Activin A Forecast
• 12.6 Asia Pacific Activin A Forecast
• 12.7 Central & South America Activin A Forecast
• 12.8 Middle East and Africa Activin A Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Activin A Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Activin A is a member of the transforming growth factor beta (TGF-β) family of proteins produced by many cell types.
The global Activin A market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Activin A market based on company, product type, end user and key regions.

This report studies the global market size of Activin A in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Activin A in these regions.
This research report categorizes the global Activin A market by top players/brands, region, type and end user. This report also studies the global Activin A market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Ajinomoto
IBL
Japan SLC
Thermo Fisher Scientific
Sigma-Aldrich
STEMCELL
PeproTech

Market size by Product
IL-4
GM-CSF
Others
Market size by End User
Human
Animal

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Activin A market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Activin A market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Activin A companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Activin A submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Activin A are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (µg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Activin A market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.